Observational Study
Copyright ©The Author(s) 2025.
World J Cardiol. Jul 26, 2025; 17(7): 101434
Published online Jul 26, 2025. doi: 10.4330/wjc.v17.i7.101434
Table 1 Baseline characteristics, median (interquartile range)

Male
Female
All participants
P value
Sample size436540608425
Age, years60 (50-69)60 (49-71)60 (50-70)0.39
Body mass index31.1 (27.2-35.3)32.6 (28.1-38.6)31.7 (27.6-36.7)< 0.01
Ethnicity, n (%)
    Mexican American858 (19.7)868 (21.4)1726 (20.5)< 0.01
    Other Hispanic370 (8.5)415 (10.2)785 (9.3)
    Non-Hispanic white1712 (39.2)1356 (33.4)3068 (36.4)
    Non-Hispanic black1006 (23.0)1059 (26.1)2065 (24.5)
    Other419 (9.6)362 (8.9)781 (9.3)
Education, n (%)
    Less than 9th grade1033 (23.7)1023 (25.2)2056 (24.4)< 0.01
    9-11th grade716 (16.4)726 (17.9)1442 (17.1)
    High school graduate1097 (25.1)996 (24.5)2093 (24.8)
    College864 (19.8)890 (21.9)1754 (20.8)
    College graduate or above632 (14.5)405 (10.0)1037 (12.3)
    Unknown23 (0.5)20 (0.5)43 (0.5)
Poverty-income ratio
    < 1797 (18.3)978 (24.1)1775 (21.1)< 0.01
    1-32224 (51.0)2182 (53.7)4406 (52.3)
    > 31344 (30.8)900 (22.2)2244 (26.6)
Smoke, n (%)
    Every day686 (15.7)466 (11.5)1152 (13.7)< 0.01
    Some days138 (3.2)85 (2.1)223 (2.6)
    Not at all1861 (42.6)986 (24.3)2847 (33.8)
    Unknown1680 (38.5)2523 (62.1)4203 (49.9)
Alcohol use
    Non-drinker1971 (45.2)2465 (60.7)4436 (52.7)< 0.01
    Drinker2393 (54.8)1592 (39.2)3985 (47.3)
    Unknown1 (0.02)3 (0.07)4 (0.05)
Hypertension, n (%)2674 (61.3)2695 (66.4)5369 (63.7)< 0.01
Hypercholesterolemia, n (%)2406 (55.1)2269 (55.9)4675 (55.5)0.49
Plasma fasting glucose, mmol/L7.55 (6.83-9.66)7.11 (6.16-8.62)7.33 (6.44-9.10)< 0.01
HbA1c, %6.7 (6.1-7.7)6.6 (6.0-7.5)6.7 (6.0-7.6)0.06
HbA1c, mmol/mol50 (43-61)49 (42-58)50 (42-60)0.06
NHHR3.14 (2.28-4.24)2.72 (1.99-3.77)2.94 (2.13-4.01)< 0.01
TC4.50 (3.83-5.35)4.91 (4.19-5.69)4.71 (3.98-5.53)< 0.01
HDL-C1.09 (0.91-1.27)1.27 (1.06-1.53)1.16 (0.98-1.42)< 0.01
LDL-C2.43 (1.81-3.13)2.69 (2.02-3.41)2.53 (1.91-3.26)< 0.01
Triglycerides0.67 (0.02-1.69)0.56 (0.02-1.69)0.67 (0.02-1.69)0.91
Table 2 Association of non-high-density lipoprotein cholesterol/high-density lipoprotein cholesterol ratio and cardiovascular mortality in patients with diabetes, hazard ratio (95% confidence intervals)
Cardiovascular mortality
Q1
Q2
Q3
Q4
Per SD
Model 1Reference0.86 (0.69-1.07)0.92 (0.74-1.14)0.86 (0.70-1.07)0.94 (0.87-1.02)
Model 2Reference1.03 (0.82-1.28)1.25 (1.01-1.55)1.40 (1.12-1.75)1.15 (1.06-1.24)
Model 3Reference1.02 (0.81-1.27)1.24 (0.99-1.54)1.39 (1.11-1.73)1.14 (1.06-1.24)
Table 3 Subgroup analyses on non-high-density lipoprotein cholesterol/high-density lipoprotein cholesterol ratio and cardiovascular mortality, hazard ratio (95% confidence intervals)
Cardiovascular mortality1
n
Q1
Q2
Q3
Q4
Per SD
P value for interaction
Gender
    Male4365Reference0.84 (0.61-1.14)1.18 (0.89-1.57)1.19 (0.88-1.59)1.12 (1.01-1.25)0.58
    Female4060Reference1.18 (0.85-1.63)1.13 (0.80-1.59)1.40 (0.99-1.97)1.09 (0.95-1.24)
Age, years
    ≥ 605161Reference1.04 (0.83-1.32)1.23 (0.97-1.54)1.31 (1.04-1.67)1.15 (1.04-1.26)0.99
    < 603264Reference1.03 (0.46-2.31)1.46 (0.71-3.03)1.89 (0.94-3.78)1.10 (0.96-1.26)
Body mass index
    ≥ 30 kg/m24738Reference1.08 (0.79-1.48)1.19 (0.87-1.63)1.35 (0.98-1.85)1.13 (1.02-1.26)0.64
    < 30 kg/m23687Reference0.93 (0.67-1.28)1.30 (0.96-1.67)1.44 (1.06-1.96)1.16 (1.03-1.31)
Duration of diabetes
    ≥ 10 years2865Reference1.06 (0.77-1.45)1.17 (0.85-1.61)1.60 (1.15-2.22)1.26 (1.11-1.42)0.04
    < 10 years5560Reference1.00 (0.72-1.37)1.35 (1.00-1.82)1.37 (1.01-1.86)1.11 (1.00-1.24)